Role of innate immunity and altered intestinal motility in LPS- and MnCl2-induced intestinal intussusception in mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 306, Issue 5, 2014, Pages

  Killoran, Kristin E ^a   Miller, Amber D ^a   Uray, Karen S ^b   Weisbrodt, Norman W ^b   Pautler, Robia G ^a   Goyert, Sanna M ^c   van Rooijen, Nico ^d   Conner, Margaret E ^a,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Inflammatory response; Intestinal disorder; Mouse model; Pediatric

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MANGANESE CHLORIDE; NITRIC OXIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; ACUTE PHASE PROTEIN; CARRIER PROTEIN; CD14 ANTIGEN; CHLORIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MANGANESE DERIVATIVE; MEMBRANE PROTEIN; TLR4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; INNATE IMMUNITY; INTESTINE CONTRACTION; INTESTINE INTUSSUSCEPTION; INTESTINE MOTILITY; INTESTINE OBSTRUCTION; LAPAROTOMY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; ULTRASOUND; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENTEROPATHY; GASTROINTESTINAL MOTILITY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; INTUSSUSCEPTION; KNOCKOUT MOUSE; METABOLISM; MOUSE MODEL; PEDIATRIC; PHYSIOLOGY; SCID MOUSE;

INFLAMMATORY RESPONSE; INTESTINAL DISORDER; MOUSE MODEL; PEDIATRIC;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIGENS, CD14; CARRIER PROTEINS; CHLORIDES; FEMALE; GASTROINTESTINAL MOTILITY; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INTUSSUSCEPTION; LIPOPOLYSACCHARIDES; MALE; MANGANESE COMPOUNDS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; TOLL-LIKE RECEPTOR 4;

EID: 84899465721     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00264.2013     Document Type: Article

References (53)

1. Badriyyah M, Mazeh H, Brocke S, Osmanova V, Freund HR, Hanani M. Prevention of lipopolysaccharide-induced intussusception in mice by the COX2 inhibitor rofecoxib. Pediatr Surg Int 24: 333-336, 2008.
2. Bines JE, Ivanoff B. Acute intussusception in infants and children. Incidence, clinical presentation and management: a global perspective. In: Vaccines and Biologicals. Geneva, Switzerland: World Health Organization, 2002.
3. Brandt ML. Intussusception. In: Oski's Pediatrics: Principles and Practice, edited by McMillan DJ, Deangelis CS, Feigin RD, Warshaw JB. Philadelphia, PA: Lippincott/Williams & Wilkins, 1999, p. 1652-1655.
4. Chan KL, Chan JK, Peh WC, Chan KW, Tam PK. Endotoxemia associated with intussusception and its diagnostic and surgical interventions. Pediatr Surg Int 18: 685-688, 2002.
5. Cohen J. The immunopathogenesis of sepsis. Nature 420: 885-891, 2002.
6. De Ponti F, D'Angelo L, Frigo GM, Crema A. Inhibitory effects of calcium channel blockers on intestinal motility in the dog. Eur J Pharmacol 168: 133-144, 1989.
7. Emoto M, Emoto Y, Brinkmann V, Miyamoto M, Yoshizawa I, Staber M, van Rooijen N, Hamann A, Kaufmann SH. Increased resistance of LFA-1-deficient mice to lipopolysaccharide-induced shock/liver injury in the presence of TNF-α and IL-12 is mediated by IL-10: a novel role for LFA-1 in the regulation of the proinflammatory and anti-inflammatory cytokine balance. J Immunol 171: 584-593, 2003.
8. Georgoula C, Ward HC. Recurrent intussusception associated with Escherichia coli 0157 infection. Dig Liver Dis 36: 557, 2004.
9. Gimondo P, Mirk P. A new method for evaluating small intestinal motility using duplex Doppler sonography. Am J Roentgenol 168: 187-192, 1997.
10. Gourcerol G, Wang L, Adelson DW, Larauche M, Tache Y, Million M. Cholinergic giant migrating contractions in conscious mouse colon assessed by using a novel noninvasive solid-state manometry method: modulation by stressors. Am J Physiol Gastrointest Liver Physiol 296: G992-G1002, 2009.
11. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94, 2001.
12. Hamlyn AN, James OF, Douglas AP, Lavelle MI, Venables CW. Caroli's disease with intrahepatic gall-stones and Salmonella infection. Postgrad Med J 52: 656-659, 1976.
13. Handley SA, Dube PH, Miller VL. Histamine signaling through the H2 receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection. Proc Natl Acad Sci USA 103: 9268-9273, 2006.
14. Hansen MG, Pearl G, Levy M. Intussusception due to Yersinia enterocolitica enterocolitis in a patient with β-thalassemia. Arch Pathol Lab Med 125: 1486-1488, 2001.
15. Itoh T, Kuriyama H, Nanjo T. Effects of calcium and manganese ions on mechanical properties of intact and skinned muscles from the guinea-pig stomach. J Physiol 333: 555-576, 1982.
16. Jakab F, Peterfai J, Verebely T, Meleg E, Banyai K, Mitchell DK, Szucs G. Human astrovirus infection associated with childhood intussusception. Pediatr Int 49: 103-105, 2007.
17. Koo JW, Cho CR, Cha SJ, Chung CY. Intussusception associated with Yersinia pseudotuberculosis infection. Acta Paediatr 85: 1253-1255, 1996.
18. Kurzbart E, Cohen Z, Yerushalmi B, Yulevich A, Newman-Heiman N, Mares AJ. Familial idiopathic intussusception: a report of two families. J Pediatr Surg 34: 493-494, 1999.
19. Li M, Johnson CP, Adams MB, Sarna SK. Cholinergic and nitrergic regulation of in vivo giant migrating contractions in rat colon. Am J Physiol Gastrointest Liver Physiol 283: G544-G552, 2002.
20. Liew FY, Komai-Koma M, Xu D. A toll for T cell costimulation. Ann Rheum Dis 63 Suppl 2: ii76-ii78, 2004.
21. Lin Z, Cohen P, Nissan A, Allweis TM, Freund HR, Hanani M. Bacterial wall lipopolysaccharide as a cause of intussusception in mice. J Pediatr Gastroenterol Nutr 27: 301-305, 1998.
22. Matsushita M, Suzaki T, Hajiro K. Intussusception associated with Salmonella typhimurium enterocolitis. Am J Gastroenterol 89: 1246-1248, 1994.
23. Mayell MJ. Intussusception in infancy and childhood in Southern Africa. A review of 223 cases. Arch Dis Child 47: 20-25, 1972.
24. Metkar S, Awasthi S, Denamur E, Kim KS, Gangloff SC, Teichberg S, Haziot A, Silver J, Goyert SM. Role of CD14 in responses to clinical isolates of Escherichia coli: effects of K1 capsule expression. Infect Immun 75: 5415-5424, 2007.
25. Miller MS, Galligan JJ, Burks TF. Accurate measurement of intestinal transit in the rat. J Pharmacol Methods 6: 211-217, 1981.
26. Montgomery EA, Popek EJ. Intussusception, adenovirus, and children: a brief reaffirmation. Hum Pathol 25: 169-174, 1994.
27. Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW, Wharton M, Livengood JR. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 344: 564-572, 2001.
28. Nissan A, Zhang JM, Lin Z, Haskel Y, Freund HR, Hanani M. The contribution of inflammatory mediators and nitric oxide to lipopolysaccharide-induced intussusception in mice. J Surg Res 69: 205-207, 1997.
29. O'Mahony DS, Pham U, Iyer R, Hawn TR, Liles WC. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages. Int J Med Sci 5: 1-8, 2008.
30. Oshio T, Ogata H, Takano S, Ishibashi H. Familial intussusception. J Pediatr Surg 42: 1509-1514, 2007.
31. Papadopoulou F, Efremidis SC. Familial intussusception. J Pediatr Surg 37: 1549-1551, 2002.
32. Peng SL. Signaling in B cells via Toll-like receptors. Curr Opin Immunol 17: 230-236, 2005.
33. Sarna SK. Molecular, functional, and pharmacological targets for the development of gut promotility drugs. Am J Physiol Gastrointest Liver Physiol 291: G545-G555, 2006.
34. Sasmono RT, David A. The biology of macrophages. In: The Innate Immune Response to Infection, edited by Kaufmann SH, Medzhitov R, Gordon S. Washington, DC: Am. Soc. Microbiol., 2004, p. 71-94.
35. Sonmez K, Karabulut R, Turkyilmaz Z, Demirogullari B, Ozen IO, Gulen S, Basaklar AC, Kale N. Association of tumor necrosis factor, interleukin-6 and cyclooxygenase pathway with lipopolysaccharide-induced intussusception. Eur J Pediatr Surg 18: 103-106, 2008.
36. Staatz G, Alzen G, Heimann G. [Intestinal infection, the most frequent cause of invagination in childhood: results of a 10-year clinical study]. Klin Padiatr 210: 61-64, 1998.
37. Stidham RW, Xu J, Johnson LA, Kim K, Moons DS, McKenna BJ, Rubin JM, Higgins PD. Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn's disease. Gastroenterology 141: 819-826, 2011.
38. Stringer MD, Holmes SJ. Familial intussusception. J Pediatr Surg 27: 1436-1437, 1992.
39. Stringer MD, Pledger G, Drake DP. Childhood deaths from intussusception in England and Wales, 1984-9. BMJ 304: 737-739, 1992.
40. Stringer MD, Willetts IE. John Hunter, Frederick Treves and intussusception. Ann R Coll Surg Engl 82: 18-23, 2000.
41. Sweet MJ, Hume DA. Endotoxin signal transduction in macrophages. J Leukoc Biol 60: 8-26, 1996.
42. To KK, Cheng VC, Hung IF, Tang BS, Wong SS, Yuen KY. Caecalcaecal intussusception caused by Trichuris trichiura in a young healthy adult. Scand J Infect Dis 38: 813-815, 2006.
43. Turkyilmaz Z, Karabulut R, Gulen S, Demirogullari B, Ozen IO, Sonmez K, Basaklar AC, Kale N. Role of nitric oxide and cyclooxygenase pathway in lipopolysaccharide-induced intussusception. Pediatr Surg Int 20: 598-601, 2004.
44. Uray KS, Laine GA, Xue H, Allen SJ, Cox CS Jr. Intestinal edema decreases intestinal contractile activity via decreased myosin light chain phosphorylation. Crit Care Med 34: 2630-2637, 2006.
45. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174: 83-93, 1994.
46. Vijay-Kumar M, Wu H, Jones R, Grant G, Babbin B, King TP, Kelly D, Gewirtz AT, Neish AS. Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. Am J Pathol 169: 1686-1700, 2006.
47. Wang P, Liu B, Ou H, Tong L, Yang J, Tang C. Nitric oxide synthase/nitric oxide pathway mediates intussusception pathogenesis in rats. Chin Med J (Engl) 112: 1016-1019, 1999.
48. Warfield KL, Blutt SE, Crawford SE, Kang G, Conner ME. Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model. J Virol 80: 12377-12386, 2006.
49. Webby RJ, Bines JE, Barnes GL, Tindall H, Krause V, Patel M. Intussusception in the Northern Territory: the incidence is low in Aboriginal and Torres Strait Islander children. J Paediatr Child Health 42: 235-239, 2006.
50. Wehner S, Behrendt FF, Lyutenski BN, Lysson M, Bauer AJ, Hirner A, Kalff JC. Inhibition of macrophage function prevents intestinal inflammation and postoperative ileus in rodents. Gut 56: 176-185, 2007.
51. Weisbrodt NW, Bass P. In vivo motility techniques. In: Handbook of Methods in Gastrointestinal Pharmacology, edited by Gaginella TS. Boca Raton, FL: CRC, 1996, p. 163-187.
52. Willetts IE, Kite P, Barclay GR, Banks RE, Rumley A, Allgar V, Stringer MD. Endotoxin, cytokines and lipid peroxides in children with intussusception. Br J Surg 88: 878-883, 2001.
53. Winesett MP, Pietsch JB, Barnard JA. Yersinia enterocolitica in a child with intussusception. J Pediatr Gastroenterol Nutr 23: 77-80, 1996.